APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Drugs and Devices

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Contraceptive Drugs and Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173980730322 December 2025193 pages

Choose your research edition.

Industry ResearchContraceptive Drugs and Devices Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Drugs and Devices Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Contraceptive Drugs and Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Drugs and Devices Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Drugs and Devices Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Contraceptive Drugs and Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Contraceptive Drugs and Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Contraceptive Drugs and Devices include Teva Pharmaceutical Industries, Merck, Pfizer, Bayer Healthcare, Warmer Chilcott, Pantarhei Bioscience, Mayer Laboratories, Church & Dwight and BioSante Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Contraceptive Drugs and Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contraceptive Drugs and Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contraceptive Drugs and Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptive Drugs and Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Contraceptive Drugs and Devices Segment by Company

Teva Pharmaceutical Industries

Merck

Pfizer

Bayer Healthcare

Warmer Chilcott

Pantarhei Bioscience

Mayer Laboratories

Church & Dwight

BioSante Pharmaceuticals

Agile Therapeutics

Contraceptive Drugs and Devices Segment by Type

Injectable Contraceptive Drugs

Vaginal

Male/Female Contraceptive Devices

Oral

Contraceptive Drugs and Devices Segment by Application

Hospitals

Pharmacies

Others

Contraceptive Drugs and Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drugs and Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drugs and Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drugs and Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptive Drugs and Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contraceptive Drugs and Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Contraceptive Drugs and Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Contraceptive Drugs and Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Contraceptive Drugs and Devices Industry Trends Table 2. Contraceptive Drugs and Devices Industry Drivers Table 3. Contraceptive Drugs and Devices Industry Opportunities and Challenges Table 4. Contraceptive Drugs and Devices Industry Restraints Table 5. Global Contraceptive Drugs and Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Contraceptive Drugs and Devices Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers Table 9. Global Contraceptive Drugs and Devices Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Contraceptive Drugs and Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Contraceptive Drugs and Devices Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Contraceptive Drugs and Devices Manufacturers, Product Type & Application Table 13. Global Contraceptive Drugs and Devices Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Contraceptive Drugs and Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injectable Contraceptive Drugs Table 17. Major Manufacturers of Vaginal Table 18. Major Manufacturers of Male/Female Contraceptive Devices Table 19. Major Manufacturers of Oral Table 20. Global Contraceptive Drugs and Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Contraceptive Drugs and Devices Sales by Type (2021-2026) & (k units) Table 22. Global Contraceptive Drugs and Devices Sales by Type (2027-2032) & (k units) Table 23. Global Contraceptive Drugs and Devices Sales Market Share by Type (2021-2026) Table 24. Global Contraceptive Drugs and Devices Sales Market Share by Type (2027-2032) Table 25. Global Contraceptive Drugs and Devices Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Contraceptive Drugs and Devices Revenue by Type (2021-2026) & (k units) Table 27. Global Contraceptive Drugs and Devices Revenue by Type (2027-2032) & (k units) Table 28. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2021-2026) Table 29. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Pharmacies Table 32. Major Manufacturers of Others Table 33. Global Contraceptive Drugs and Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Contraceptive Drugs and Devices Sales by Application (2021-2026) & (k units) Table 35. Global Contraceptive Drugs and Devices Sales by Application (2027-2032) & (k units) Table 36. Global Contraceptive Drugs and Devices Sales Market Share by Application (2021-2026) Table 37. Global Contraceptive Drugs and Devices Sales Market Share by Application (2027-2032) Table 38. Global Contraceptive Drugs and Devices Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Contraceptive Drugs and Devices Revenue by Application (2021-2026) & (k units) Table 40. Global Contraceptive Drugs and Devices Revenue by Application (2027-2032) & (k units) Table 41. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2021-2026) Table 42. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2027-2032) Table 43. Global Contraceptive Drugs and Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Contraceptive Drugs and Devices Sales by Region (2021-2026) & (k units) Table 45. Global Contraceptive Drugs and Devices Sales Market Share by Region (2021-2026) Table 46. Global Contraceptive Drugs and Devices Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Contraceptive Drugs and Devices Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Contraceptive Drugs and Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 50. North America Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 51. Europe Contraceptive Drugs and Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 53. Europe Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Contraceptive Drugs and Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Contraceptive Drugs and Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2027-2032) & (k units) Table 60. Global Contraceptive Drugs and Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Contraceptive Drugs and Devices Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Contraceptive Drugs and Devices Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2021-2026) Table 64. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2027-2032) Table 65. Teva Pharmaceutical Industries Company Information Table 66. Teva Pharmaceutical Industries Business Overview Table 67. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio Table 69. Teva Pharmaceutical Industries Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck Contraceptive Drugs and Devices Product Portfolio Table 74. Merck Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Contraceptive Drugs and Devices Product Portfolio Table 79. Pfizer Recent Development Table 80. Bayer Healthcare Company Information Table 81. Bayer Healthcare Business Overview Table 82. Bayer Healthcare Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio Table 84. Bayer Healthcare Recent Development Table 85. Warmer Chilcott Company Information Table 86. Warmer Chilcott Business Overview Table 87. Warmer Chilcott Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio Table 89. Warmer Chilcott Recent Development Table 90. Pantarhei Bioscience Company Information Table 91. Pantarhei Bioscience Business Overview Table 92. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio Table 94. Pantarhei Bioscience Recent Development Table 95. Mayer Laboratories Company Information Table 96. Mayer Laboratories Business Overview Table 97. Mayer Laboratories Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio Table 99. Mayer Laboratories Recent Development Table 100. Church & Dwight Company Information Table 101. Church & Dwight Business Overview Table 102. Church & Dwight Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Church & Dwight Contraceptive Drugs and Devices Product Portfolio Table 104. Church & Dwight Recent Development Table 105. BioSante Pharmaceuticals Company Information Table 106. BioSante Pharmaceuticals Business Overview Table 107. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio Table 109. BioSante Pharmaceuticals Recent Development Table 110. Agile Therapeutics Company Information Table 111. Agile Therapeutics Business Overview Table 112. Agile Therapeutics Contraceptive Drugs and Devices Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio Table 114. Agile Therapeutics Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Contraceptive Drugs and Devices Distributors List Table 118. Contraceptive Drugs and Devices Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Contraceptive Drugs and Devices Product Image Figure 2. Global Contraceptive Drugs and Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Drugs and Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Contraceptive Drugs and Devices Sales (2021-2032) & (k units) Figure 5. Global Contraceptive Drugs and Devices Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Contraceptive Drugs and Devices Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injectable Contraceptive Drugs Image Figure 9. Vaginal Image Figure 10. Male/Female Contraceptive Devices Image Figure 11. Oral Image Figure 12. Global Contraceptive Drugs and Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Contraceptive Drugs and Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Contraceptive Drugs and Devices Sales Market Share by Type (2021-2032) Figure 15. Global Contraceptive Drugs and Devices Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Contraceptive Drugs and Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Pharmacies Image Figure 20. Others Image Figure 21. Global Contraceptive Drugs and Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Contraceptive Drugs and Devices Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Contraceptive Drugs and Devices Sales Market Share by Application (2021-2032) Figure 24. Global Contraceptive Drugs and Devices Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Contraceptive Drugs and Devices Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2021-2032) Figure 27. North America Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Contraceptive Drugs and Devices Sales Market Share by Country (2021-2032) Figure 29. U.S. Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Contraceptive Drugs and Devices Sales Market Share by Country (2021-2032) Figure 34. Germany Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Country (2021-2032) Figure 41. China Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Country (2021-2032) Figure 49. Brazil Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Contraceptive Drugs and Devices Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Contraceptive Drugs and Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Contraceptive Drugs and Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Figure 60. North America Contraceptive Drugs and Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Figure 62. Europe Contraceptive Drugs and Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Contraceptive Drugs and Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Contraceptive Drugs and Devices Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Contraceptive Drugs and Devices Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Contraceptive Drugs and Devices Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Contraceptive Drugs and Devices Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Contraceptive Drugs
  • Vaginal
  • Male/Female Contraceptive Devices
  • Oral
Applications
  • Hospitals
  • Pharmacies
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Merck
  • Pfizer
  • Bayer Healthcare
  • Warmer Chilcott
  • Pantarhei Bioscience
  • Mayer Laboratories
  • Church & Dwight
  • BioSante Pharmaceuticals
  • Agile Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Contraceptive Drugs and Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Contraceptive Drugs and Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Contraceptive Drugs and Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Contraceptive Drugs and Devices Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Contraceptive Drugs and Devices Market Dynamics
  1. 2.1 Contraceptive Drugs and Devices Industry Trends
  2. 2.2 Contraceptive Drugs and Devices Industry Drivers
  3. 2.3 Contraceptive Drugs and Devices Industry Opportunities and Challenges
  4. 2.4 Contraceptive Drugs and Devices Industry Restraints
3 Contraceptive Drugs and Devices Market by Manufacturers
  1. 3.1 Global Contraceptive Drugs and Devices Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Contraceptive Drugs and Devices Sales by Manufacturers (2021-2026)
  3. 3.3 Global Contraceptive Drugs and Devices Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Contraceptive Drugs and Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contraceptive Drugs and Devices Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Contraceptive Drugs and Devices Manufacturers, Product Type & Application
  7. 3.7 Global Contraceptive Drugs and Devices Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contraceptive Drugs and Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contraceptive Drugs and Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contraceptive Drugs and Devices Tier 1, Tier 2, and Tier 3
4 Contraceptive Drugs and Devices Market by Type
  1. 4.1 Contraceptive Drugs and Devices Type Introduction
  2. 4.1.1 Injectable Contraceptive Drugs
  3. 4.1.2 Vaginal
  4. 4.1.3 Male/Female Contraceptive Devices
  5. 4.1.4 Oral
  6. 4.2 Global Contraceptive Drugs and Devices Sales by Type
  7. 4.2.1 Global Contraceptive Drugs and Devices Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Contraceptive Drugs and Devices Sales by Type (2021-2032)
  9. 4.2.3 Global Contraceptive Drugs and Devices Sales Market Share by Type (2021-2032)
  10. 4.3 Global Contraceptive Drugs and Devices Revenue by Type
  11. 4.3.1 Global Contraceptive Drugs and Devices Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Contraceptive Drugs and Devices Revenue by Type (2021-2032)
  13. 4.3.3 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2021-2032)
5 Contraceptive Drugs and Devices Market by Application
  1. 5.1 Contraceptive Drugs and Devices Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Pharmacies
  4. 5.1.3 Others
  5. 5.2 Global Contraceptive Drugs and Devices Sales by Application
  6. 5.2.1 Global Contraceptive Drugs and Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contraceptive Drugs and Devices Sales by Application (2021-2032)
  8. 5.2.3 Global Contraceptive Drugs and Devices Sales Market Share by Application (2021-2032)
  9. 5.3 Global Contraceptive Drugs and Devices Revenue by Application
  10. 5.3.1 Global Contraceptive Drugs and Devices Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Contraceptive Drugs and Devices Revenue by Application (2021-2032)
  12. 5.3.3 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2021-2032)
6 Global Contraceptive Drugs and Devices Sales by Region
  1. 6.1 Global Contraceptive Drugs and Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contraceptive Drugs and Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Contraceptive Drugs and Devices Sales by Region (2021-2026)
  4. 6.2.2 Global Contraceptive Drugs and Devices Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Contraceptive Drugs and Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Contraceptive Drugs and Devices Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Contraceptive Drugs and Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Contraceptive Drugs and Devices Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Contraceptive Drugs and Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Contraceptive Drugs and Devices Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Contraceptive Drugs and Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Contraceptive Drugs and Devices Revenue by Region
  1. 7.1 Global Contraceptive Drugs and Devices Revenue by Region
  2. 7.1.1 Global Contraceptive Drugs and Devices Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Contraceptive Drugs and Devices Revenue by Region (2021-2026)
  4. 7.1.3 Global Contraceptive Drugs and Devices Revenue by Region (2027-2032)
  5. 7.1.4 Global Contraceptive Drugs and Devices Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Contraceptive Drugs and Devices Revenue (2021-2032)
  8. 7.2.2 North America Contraceptive Drugs and Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Contraceptive Drugs and Devices Revenue (2021-2032)
  11. 7.3.2 Europe Contraceptive Drugs and Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Contraceptive Drugs and Devices Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Contraceptive Drugs and Devices Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Contraceptive Drugs and Devices Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Contraceptive Drugs and Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Contraceptive Drugs and Devices Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Contraceptive Drugs and Devices Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Bayer Healthcare
  20. 8.4.1 Bayer Healthcare Company Information
  21. 8.4.2 Bayer Healthcare Business Overview
  22. 8.4.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio
  24. 8.4.5 Bayer Healthcare Recent Developments
  25. 8.5 Warmer Chilcott
  26. 8.5.1 Warmer Chilcott Company Information
  27. 8.5.2 Warmer Chilcott Business Overview
  28. 8.5.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio
  30. 8.5.5 Warmer Chilcott Recent Developments
  31. 8.6 Pantarhei Bioscience
  32. 8.6.1 Pantarhei Bioscience Company Information
  33. 8.6.2 Pantarhei Bioscience Business Overview
  34. 8.6.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio
  36. 8.6.5 Pantarhei Bioscience Recent Developments
  37. 8.7 Mayer Laboratories
  38. 8.7.1 Mayer Laboratories Company Information
  39. 8.7.2 Mayer Laboratories Business Overview
  40. 8.7.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio
  42. 8.7.5 Mayer Laboratories Recent Developments
  43. 8.8 Church & Dwight
  44. 8.8.1 Church & Dwight Company Information
  45. 8.8.2 Church & Dwight Business Overview
  46. 8.8.3 Church & Dwight Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Church & Dwight Contraceptive Drugs and Devices Product Portfolio
  48. 8.8.5 Church & Dwight Recent Developments
  49. 8.9 BioSante Pharmaceuticals
  50. 8.9.1 BioSante Pharmaceuticals Company Information
  51. 8.9.2 BioSante Pharmaceuticals Business Overview
  52. 8.9.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio
  54. 8.9.5 BioSante Pharmaceuticals Recent Developments
  55. 8.10 Agile Therapeutics
  56. 8.10.1 Agile Therapeutics Company Information
  57. 8.10.2 Agile Therapeutics Business Overview
  58. 8.10.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio
  60. 8.10.5 Agile Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contraceptive Drugs and Devices Value Chain Analysis
  2. 9.1.1 Contraceptive Drugs and Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contraceptive Drugs and Devices Production Mode & Process
  6. 9.2 Contraceptive Drugs and Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contraceptive Drugs and Devices Distributors
  9. 9.2.3 Contraceptive Drugs and Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst